Parasites, Hosts and Diseases

"Pascal Ringwald"

Original Article

Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand: Srivicha Krudsood, Noppadon Tangpukdee, Sant Muangnoicharoen, Vipa Thanachartwet, Nutthanej Luplertlop, Siripan Srivilairit, Polrat Wilairatana, Shigeyuki Kano, Pascal Ringwald, Sornchai Looareesuwan; Korean J Parasitol 2007;45(2):111-114.
Published online June 20, 2007; DOI: https://doi.org/10.3347/kjp.2007.45.2.111

Abstract
PDF

Chloroquine remains the drug of choice for the treatment of vivax malaria in Thailand. Mixed infections of falciparum and vivax malaria are also common in South-East Asia. Laboratory confirmation of malaria species is not generally available. This study aimed to find alternative regimens for treating both malaria species by using falciparum antimalarial drugs. From June 2004 to May 2005, 98 patients with Plasmodium vivax were randomly treated with either artemether-lumefantrine (n = 47) or chloroquine (n = 51). Both treatments were followed by 15 mg of primaquine over 14 days. Adverse events and clinical and parasitological outcomes were recorded and revealed similar in both groups. The cure rate was 97.4% for the artemether-lumefantrine treated group and 100% for the chloroquine treated group. We concluded that the combination of artemether-lumefantrine and primaquine was well tolerated, as effective as chloroquine and primaquine, and can be an alternative regimen for treatment of vivax malaria especially in the event that a mixed infection of falciparum and vivax malaria could not be ruled out.

Citations

Citations to this article as recorded by

Drug resistance markers in Plasmodium vivax isolates from a Kanchanaburi province, Thailand between January to May 2023
Thanawat Sridapan, Paweesuda Rattanakoch, Kaewkanha Kijprasong, Suttipat Srisutham, Kristan Alexander Schneider
PLOS ONE.2024; 19(7): e0304337. CrossRef
Adapted Guidelines for Malaria Case Management in Sudan
Samah Elhassan, Sahar Khalid Mohamed, Khlood Fathi Hassan Alnaeem, Ahmed Abdulgadir Noureddin, Samah Kamaleldeen Bakrri Abass, Fadwa Mohamed Saad, Technical Advisory Committee
Sudan Journal of Medical Sciences.2024; 19(4): 531. CrossRef
Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes
Lisa H. Verzier, Rachael Coyle, Shivani Singh, Theo Sanderson, Julian C. Rayner, Paulo Pimenta
PLOS Neglected Tropical Diseases.2019; 13(6): e0007470. CrossRef
Management of relapsingPlasmodium vivaxmalaria
Cindy S Chu, Nicholas J White
Expert Review of Anti-infective Therapy.2016; 14(10): 885. CrossRef
Evaluation of Efficacy of Chloroquine for Plasmodium Vivax Infection Using Parasite Clearance Times: A 10-Year Study and Systematic Review
Hariharan Subramony, Noppadon Tangpukdee, Srivicha Krudsood, Kittiyod Poovorawan, Sant Muangnoicharoen, Polrat Wilairatana
Annals of the Academy of Medicine, Singapore.2016; 45(7): 303. CrossRef
Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review
Benjamin J Visser, Rosanne W Wieten, Daniëlle Kroon, Ingeborg M Nagel, Sabine Bélard, Michèle van Vugt, Martin P Grobusch
Malaria Journal.2014;[Epub] CrossRef
Malaria: an update on current chemotherapy
Benjamin J Visser, Michèle van Vugt, Martin P Grobusch
Expert Opinion on Pharmacotherapy.2014; 15(15): 2219. CrossRef
Effectiveness of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax and P. falciparum Malaria in Young Children in Papua New Guinea
Nicolas Senn, Patricia Rarau, Doris Manong, Mary Salib, Peter Siba, John C. Reeder, Stephen J. Rogerson, Blaise Genton, Ivo Mueller
Clinical Infectious Diseases.2013; 56(10): 1413. CrossRef
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
Nithya Gogtay, Sridharan Kannan, Urmila M Thatte, Piero L Olliaro, David Sinclair
Cochrane Database of Systematic Reviews.2013;[Epub] CrossRef
Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan
Tajeldin M Abdallah, Abdel Aziem A Ali, Mohammed Bakri, Gasim I Gasim, Imad R Musa, Ishag Adam
Malaria Journal.2012;[Epub] CrossRef
Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana
Daniel Eibach, Nicolas Ceron, Karanchand Krishnalall, Keith Carter, Guillaume Bonnot, Anne-Lise Bienvenu, Stéphane Picot
Malaria Journal.2012;[Epub] CrossRef
Coartem®: a decade of patient-centric malaria management
Kamal Hamed, Heiner Grueninger
Expert Review of Anti-infective Therapy.2012; 10(6): 645. CrossRef
Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia
Teferi Eshetu, Nasir Abdo, Kunuz H Bedru, Sintayehu Fekadu, Andreas Wieser, Michael Pritsch, Thomas Löscher, Nicole Berens-Riha
Malaria Journal.2012;[Epub] CrossRef
Primaquine in vivax malaria: an update and review on management issues
Deepika Fernando, Chaturaka Rodrigo, Senaka Rajapakse
Malaria Journal.2011;[Epub] CrossRef
Plasmodium vivax treatments
Ric N. Price, Nicholas M. Douglas, Nicholas M. Anstey, Lorenz von Seidlein
Current Opinion in Infectious Diseases.2011; 24(6): 578. CrossRef
Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial
Yi Poravuth, Duong Socheat, Ronnatrai Rueangweerayut, Chirapong Uthaisin, Aung Pyae Phyo, Neena Valecha, B. H. Krishnamoorthy Rao, Emiliana Tjitra, Asep Purnama, Isabelle Borghini-Fuhrer, Stephan Duparc, Chang-Sik Shin, Lawrence Fleckenstein, Lorenz von S
PLoS ONE.2011; 6(1): e14501. CrossRef
The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
Quique Bassat, David Joseph Diemert
PLoS Neglected Tropical Diseases.2011; 5(12): e1325. CrossRef
Confirmed Vivax Resistance to Chloroquine and Effectiveness of Artemether-Lumefantrine for the Treatment of Vivax Malaria in Ethiopia
Ambachew M. Yohannes, Pascal Ringwald, Awash Teklehaimanot, Yngve Bergqvist
The American Journal of Tropical Medicine and Hygiene.2011; 84(1): 137. CrossRef
Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries
Cho Naing, Kyan Aung, Daw-Khin Win, Mak Joon Wah
Transactions of the Royal Society of Tropical Medicine and Hygiene.2010; 104(11): 695. CrossRef
Artemisinin combination therapy for vivax malaria
Nicholas M Douglas, Nicholas M Anstey, Brian J Angus, Francois Nosten, Ric N Price
The Lancet Infectious Diseases.2010; 10(6): 405. CrossRef
The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies
J. D. Maguire, J. K. Baird
Annals of Tropical Medicine & Parasitology.2010; 104(4): 283. CrossRef
Application of mobile-technology for disease and treatment monitoring of malaria in the "Better Border Healthcare Programme"
Pongthep Meankaew, Jaranit Kaewkungwal, Amnat Khamsiriwatchara, Podjadeach Khunthong, Pratap Singhasivanon, Wichai Satimai
Malaria Journal.2010;[Epub] CrossRef
Resistance to Therapies for Infection byPlasmodium vivax
J. Kevin Baird
Clinical Microbiology Reviews.2009; 22(3): 508. CrossRef